14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
12:00–13:00<br />
Hepatitis C<br />
Poster Sessions Tuesday, May 4, 2004<br />
P1565 Pegylated interferon-alpha2a <strong>and</strong> ribavirin in<br />
HIV-HCV co-infected patients<br />
G. Cariti, S. Bonora, F.G. De Rosa, O. Bargiacchi,<br />
S. Audagnotto, D. Aguilar, F. Lipani, M. Bonasso,<br />
C. Tettoni, A. Poggio, M. Gobber, P.G. Orsi,<br />
M. Anselmo, F. Indiveri, G. Ferrea, A. Sinicco,<br />
T. De Blasi, R. Raiteri, G. Di Perri (Turin, Verbania,<br />
Vercelli, Aless<strong>and</strong>ria, Savona, Genoa, Sanremo, I)<br />
P1566 Compliance <strong>and</strong> response to PEG-IFNalpha<br />
<strong>and</strong> Ribavirin combined treatment <strong>of</strong> a special<br />
category <strong>of</strong> chronic hepatitis C patients,<br />
the ex-users <strong>of</strong> intravenously administered<br />
narcotic substances<br />
C. Drakoulis, E. Stavropoulou, E. Nikitidis,<br />
S. Nikolaou, C. Malli, E. Katsadorou, M. Minadaki<br />
(Piraeus, GR)<br />
P1567 Effects <strong>of</strong> combination treatment with<br />
interferon <strong>and</strong> ribavirin on endothelial cell<br />
inflammatory integrins <strong>and</strong> stress markers in<br />
advanced chronic hepatitis C<br />
I. Korzh, I. Fedotova, V. Nemtsova (Kharkov, UKR)<br />
P1568 Influence <strong>of</strong> interleukin-10 therapy on<br />
endothelial cell proteins in patients with<br />
chronic hepatitis C<br />
O. Korzh (Kharkov, UKR)<br />
P1569 Correlation between endothelial haemostatic<br />
markers in patients with chronic hepatitis C<br />
O. Korzh (Kharkov, UKR)<br />
P1570 The role <strong>of</strong> antibodies against NS5 protein <strong>of</strong><br />
hepatitis C virus (HCV) <strong>and</strong> IgM antibodies<br />
against HCV as predictive factors to the<br />
treatment with interferon alpha in patients<br />
with chronic hepatitis C<br />
V. Mitsura (Gomel, BLR)<br />
P1571 Evaluation <strong>of</strong> the total hepatitis C virus core<br />
antigen in patients with chronic hepatitis:<br />
comparison with quantiplex branched<br />
DNA 3.0<br />
G. Giuliani, P. Musardo, L. Drago, A. Lombardi,<br />
M.R. Gismondo (Milan, I)<br />
P1572 Rapid <strong>and</strong> accurate quantitation <strong>of</strong> different<br />
HCV genotypes by optimisation <strong>of</strong> a new<br />
real-time PCR test<br />
L. Tagliaferro, P. Menegazzi, M. De Donno,<br />
J.L. McDermott, F. Bertolotti, I. Martini,<br />
O.E. Varnier (Lecce, Genoa, I)<br />
P1573 Genotyping distribution <strong>of</strong> hepatitis C virus<br />
in patients with HCV infection in Northern<br />
Greece<br />
A. Tatsiopoulos, K. M<strong>and</strong>raveli, D. Papadopoulou,<br />
S. Alexiou-Daniel (Thessalonica, GR)<br />
P1574 Use <strong>of</strong> transcription mediated amplification<br />
method (TMA), line probe assay (LiPA) <strong>and</strong><br />
branched DNA (bDNA) assay, to study chronic<br />
hepatitis C in a group <strong>of</strong> intravenous drug<br />
users<br />
M. Christ<strong>of</strong>idou, G. Economides,<br />
G. Dimitracopoulos (Patras, GR)<br />
P1575 Molecular epidemiology <strong>of</strong> hepatitis C<br />
among drug users, correlation with clinical<br />
parameters, sexual behaviour <strong>and</strong> drugrelated<br />
risk behaviour<br />
C. Matheï, G. Robaeys, M. Van Ranst,<br />
P. Van Damme, F. Buntinx<br />
(Leuven, Genk, Antwerp, B)<br />
P1576 Evaluation <strong>of</strong> total HCV core antigen<br />
detection in hemodialysis patients<br />
A.I. Aller, L. Calbo, J.L. De Francisco, J.C. Alados,<br />
C. De Miguel (Jerez de la Frontera, E)<br />
P1577 <strong>Clinical</strong> evaluation <strong>of</strong> the male sexual partners<br />
<strong>of</strong> HCV-infected pregnant women<br />
E. Minola, C. Passerini Tosi, G. Rizzo, M. Arosio,<br />
A. Goglio, F. Suter (Bergamo, I)<br />
P1578 Outcome <strong>of</strong> pregnancy in hepatitis C virus<br />
infection<br />
A. Sariola, P. Koskela, P. Finne, A. Järvenpää,<br />
K. Melen, S. Riikonen, I. Julkunen (Helsinki, FIN)<br />
P1579 Prevalence <strong>of</strong> hepatitis C virus infection <strong>and</strong><br />
risk factors in an incarcerated population in<br />
Iran<br />
Z Mohtasham Amiri, M. Rezvani, M.A. Jafari<br />
Shakib, R. Jafari Shakib, H. Asadi Nejad<br />
(Rasht, IR)<br />
P1580 HCV genotypes in the Slovak Republic<br />
K. Koncova, J. Kazar (Bratislava, SK)<br />
P1581 Genotypical pr<strong>of</strong>ile <strong>of</strong> infection by HCV<br />
D. Blanco, A. Marin, I. Gonzalez, M. Nuñez,<br />
M. Viqueira, A. Gomez, J. Piqueras (Cartagena, E)<br />
P1582 Distribution <strong>of</strong> HCV genotypes among<br />
patients in São Paulo, Brazil<br />
H.H. Caiaffa Filho, A.Z.A. Latif, P.R. Canesin,<br />
A.C. Lucena, M.N. Burattini (São Paulo, BR)<br />
www.escmid.org/eccmid2004<br />
page 129
Change language